BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18628528)

  • 1. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
    Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
    Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
    Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
    Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium/iodide symporter mRNA expression in cold thyroid nodules.
    Paschke R; Neumann S
    Exp Clin Endocrinol Diabetes; 2001; 109(1):45-6. PubMed ID: 11573139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors.
    Galrão AL; Camargo RY; Friguglietti CU; Moraes L; Cerutti JM; Serrano-Nascimento C; Suzuki MF; Medeiros-Neto G; Rubio IG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E944-52. PubMed ID: 24432988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium iodide symporter and pendrin expression in human thyroid tissues.
    Mian C; Lacroix L; Alzieu L; Nocera M; Talbot M; Bidart JM; Schlumberger M; Caillou B
    Thyroid; 2001 Sep; 11(9):825-30. PubMed ID: 11575851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
    Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
    Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
    J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
    Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
    Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression.
    Galrão AL; Sodré AK; Camargo RY; Friguglietti CU; Kulcsar MA; Lima EU; Medeiros-Neto G; Rubio IG
    Endocrine; 2013 Feb; 43(1):225-9. PubMed ID: 22945693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.